Prof. Dr. Johannes Schetelig (r.), Director Clinical Research at DKMS and Head of Stem Cell Transplantation Unit at the University Hospital Carl Gustav Carus Dresden, Germany. (IMAGE)

DKMS

Prof. Dr. Johannes Schetelig (r.), Director Clinical Research at DKMS and Head of Stem Cell Transplantation Unit at the University Hospital Carl Gustav Carus Dresden, Germany.

Caption

The ASAP trial sets new perspectives on international therapy standards: High-dose chemotherapy is not always necessary before transplantation in cases of acute myeloid leukemia (AML). This means patients can proceed to transplantation much faster [1].

Credit

© DKMS (Photo: Tobias Ebert)

Usage Restrictions

No restriction. Please credit.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.